2010, ISBN 0803220332, xi, 398
Book
Colloids and Surfaces B: Biointerfaces, ISSN 0927-7765, 2007, Volume 59, Issue 1, pp. 24 - 34
Chitosan nanoparticles fabricated via different preparation protocols have been in recent years widely studied as carriers for therapeutic proteins and genes...
Protein encapsulation | Protein controlled release | Chitosan | Chitosan nanoparticle | chitosan | MATERIALS SCIENCE, BIOMATERIALS | MOLECULAR-WEIGHT | GENE DELIVERY | MICROSPHERES | DRUG-DELIVERY | ALGINATE | protein controlled release | TRANSFECTION EFFICIENCY | CHEMISTRY, PHYSICAL | chitosan nanoparticle | BEADS | protein encapsulation | BIOPHYSICS | IN-VIVO | DNA NANOPARTICLES | BOVINE SERUM-ALBUMIN | Microscopy, Electron, Transmission | Biocompatible Materials - isolation & purification | Molecular Weight | Nanoparticles - chemistry | Serum Albumin, Bovine - administration & dosage | Biocompatible Materials - chemistry | Nanoparticles - ultrastructure | Chemistry, Physical | Drug Carriers - chemistry | Particle Size | Animals | Chitosan - chemistry | Membrane Potentials | Cattle | Proteins - administration & dosage | Chemical Phenomena | In Vitro Techniques | Chitosan - isolation & purification | Polyphosphates - chemistry | Proteins | Chitin | Nanotechnology
Protein encapsulation | Protein controlled release | Chitosan | Chitosan nanoparticle | chitosan | MATERIALS SCIENCE, BIOMATERIALS | MOLECULAR-WEIGHT | GENE DELIVERY | MICROSPHERES | DRUG-DELIVERY | ALGINATE | protein controlled release | TRANSFECTION EFFICIENCY | CHEMISTRY, PHYSICAL | chitosan nanoparticle | BEADS | protein encapsulation | BIOPHYSICS | IN-VIVO | DNA NANOPARTICLES | BOVINE SERUM-ALBUMIN | Microscopy, Electron, Transmission | Biocompatible Materials - isolation & purification | Molecular Weight | Nanoparticles - chemistry | Serum Albumin, Bovine - administration & dosage | Biocompatible Materials - chemistry | Nanoparticles - ultrastructure | Chemistry, Physical | Drug Carriers - chemistry | Particle Size | Animals | Chitosan - chemistry | Membrane Potentials | Cattle | Proteins - administration & dosage | Chemical Phenomena | In Vitro Techniques | Chitosan - isolation & purification | Polyphosphates - chemistry | Proteins | Chitin | Nanotechnology
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 09/2015, Volume 175, Issue 9, pp. 1461 - 1472
IMPORTANCE: Cognitive behavioral therapy for insomnia (CBT-I) is the most prominent nonpharmacologic treatment for insomnia disorders. Although meta-analyses...
BREAST-CANCER | SLEEP DISTURBANCE | MEDICINE, GENERAL & INTERNAL | PRIMARY-CARE | CHRONIC PAIN | CLINICAL-TRIAL | OLDER-ADULTS | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | ANXIETY DISORDERS | PERSISTENT INSOMNIA | Sleep Initiation and Maintenance Disorders - complications | Mental Disorders - therapy | Sleep | Humans | Sleep Initiation and Maintenance Disorders - therapy | Cognitive Therapy | Mental Disorders - complications | Treatment Outcome | Cognitive therapy | Usage | Care and treatment | Insomnia | Management | Psychiatry | Health aspects | PTSD | Treatment Effectiveness | Sleep Behavior | Comorbidity | Systematic Review | Remission | Adults | Cognitive Behavioral Therapy | Psychiatric Disorders | Somatic Symptoms | Diseases
BREAST-CANCER | SLEEP DISTURBANCE | MEDICINE, GENERAL & INTERNAL | PRIMARY-CARE | CHRONIC PAIN | CLINICAL-TRIAL | OLDER-ADULTS | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | ANXIETY DISORDERS | PERSISTENT INSOMNIA | Sleep Initiation and Maintenance Disorders - complications | Mental Disorders - therapy | Sleep | Humans | Sleep Initiation and Maintenance Disorders - therapy | Cognitive Therapy | Mental Disorders - complications | Treatment Outcome | Cognitive therapy | Usage | Care and treatment | Insomnia | Management | Psychiatry | Health aspects | PTSD | Treatment Effectiveness | Sleep Behavior | Comorbidity | Systematic Review | Remission | Adults | Cognitive Behavioral Therapy | Psychiatric Disorders | Somatic Symptoms | Diseases
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2015, Volume 3, Issue 12, p. CD010523
Background Personalised care planning is a collaborative process used in chronic condition management in which patients and clinicians identify and discuss...
LOW-INCOME PATIENTS | SHARED DECISION-MAKING | 1-YEAR FOLLOW-UP | MEDICINE, GENERAL & INTERNAL | COLLABORATIVE CARE | COST-EFFECTIVENESS | SELF-MANAGEMENT SUPPORT | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | CORONARY-HEART-DISEASE | PATIENT-CENTERED CARE | Diabetes Mellitus - blood | Glycated Hemoglobin A - analysis | Mental Disorders - therapy | Humans | Patient Participation | Randomized Controlled Trials as Topic | Kidney Failure, Chronic - therapy | Heart Failure - therapy | Patient Care Planning | Diabetes Mellitus - therapy | Chronic Disease - therapy | Adult | Asthma - therapy | Health Status | Self Care
LOW-INCOME PATIENTS | SHARED DECISION-MAKING | 1-YEAR FOLLOW-UP | MEDICINE, GENERAL & INTERNAL | COLLABORATIVE CARE | COST-EFFECTIVENESS | SELF-MANAGEMENT SUPPORT | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | CORONARY-HEART-DISEASE | PATIENT-CENTERED CARE | Diabetes Mellitus - blood | Glycated Hemoglobin A - analysis | Mental Disorders - therapy | Humans | Patient Participation | Randomized Controlled Trials as Topic | Kidney Failure, Chronic - therapy | Heart Failure - therapy | Patient Care Planning | Diabetes Mellitus - therapy | Chronic Disease - therapy | Adult | Asthma - therapy | Health Status | Self Care
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 5, pp. 680 - 692
Abstract Fibromyalgia is the currently preferred term for widespread musculoskeletal pain, typically accompanied by other symptoms such as fatigue, memory...
Internal Medicine | INTRINSIC BRAIN CONNECTIVITY | FUNCTIONAL SOMATIC SYNDROMES | RANDOMIZED CONTROLLED-TRIALS | MEDICINE, GENERAL & INTERNAL | CENTRAL SENSITIZATION | GENERAL-POPULATION | CHRONIC PAIN | DOUBLE-BLIND | LOW-DOSE NALTREXONE | RHEUMATIC-DISEASES | SYMPTOM SEVERITY | Fibromyalgia - therapy | Fibromyalgia - complications | Fibromyalgia - diagnosis | Fibromyalgia - etiology | Humans | Fibromyalgia | Care and treatment | Diagnosis
Internal Medicine | INTRINSIC BRAIN CONNECTIVITY | FUNCTIONAL SOMATIC SYNDROMES | RANDOMIZED CONTROLLED-TRIALS | MEDICINE, GENERAL & INTERNAL | CENTRAL SENSITIZATION | GENERAL-POPULATION | CHRONIC PAIN | DOUBLE-BLIND | LOW-DOSE NALTREXONE | RHEUMATIC-DISEASES | SYMPTOM SEVERITY | Fibromyalgia - therapy | Fibromyalgia - complications | Fibromyalgia - diagnosis | Fibromyalgia - etiology | Humans | Fibromyalgia | Care and treatment | Diagnosis
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2010, Volume 2010, Issue 1, p. CD003974
Background Placebo interventions are often claimed to substantially improve patient-reported and observer-reported outcomes in many clinical conditions, but...
LOW-BACK-PAIN | ELECTRICAL NERVE-STIMULATION | CHEMOTHERAPY-INDUCED NAUSEA | Placebo Effect | Humans | Treatment Outcome | RANDOMIZED CONTROLLED-TRIAL | Refusal to Treat | Randomized Controlled Trials as Topic | ADOLESCENT BLOOD-PRESSURE | MEDICINE, GENERAL & INTERNAL | TRANSMUCOSAL FENTANYL CITRATE | CRUCIATE LIGAMENT RECONSTRUCTION | P6 ACUPUNCTURE ANTIEMESIS | COGNITIVE-BEHAVIOR THERAPY | RESPIRATORY-TRACT INFECTIONS | Nausea - prevention & control | Pain - prevention & control
LOW-BACK-PAIN | ELECTRICAL NERVE-STIMULATION | CHEMOTHERAPY-INDUCED NAUSEA | Placebo Effect | Humans | Treatment Outcome | RANDOMIZED CONTROLLED-TRIAL | Refusal to Treat | Randomized Controlled Trials as Topic | ADOLESCENT BLOOD-PRESSURE | MEDICINE, GENERAL & INTERNAL | TRANSMUCOSAL FENTANYL CITRATE | CRUCIATE LIGAMENT RECONSTRUCTION | P6 ACUPUNCTURE ANTIEMESIS | COGNITIVE-BEHAVIOR THERAPY | RESPIRATORY-TRACT INFECTIONS | Nausea - prevention & control | Pain - prevention & control
Journal Article